Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 3/20 | 0.54 |
| ▸ | BCHE | P06276 | 2/20 | 0.54 |
| ▸ | LSS | P48449 | 1/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5752214 | 1.00 | KCNH2 (0.62) | KCNH2RAB9AACHEBCHELSS | |
| SCHEMBL9779266 | 0.86 | NR1I2 (0.60) | KCNH2ACHEBCHELSS | |
| SCHEMBL5754753 | 0.82 | LSS (0.55) | KCNH2ACHEBCHELSS | |
| SCHEMBL5754749 | 0.82 | LSS (0.55) | KCNH2ACHEBCHELSS | |
| SCHEMBL13435489 | 0.80 | MEN1 (0.70) | KCNH2RAB9ABCHETRPA1 | |
| SCHEMBL16039094 | 0.79 | ACHE (0.76) | ACHEBCHE | |
| SCHEMBL20871186 | 0.79 | TRPA1 (0.56) | RAB9ATRPA1 | |
| SCHEMBL19249418 | 0.79 | KCNH2 (0.95) | KCNH2 | |
| SCHEMBL15105021 | 0.78 | TRPA1 (0.63) | RAB9ATRPA1 | |
| SCHEMBL3869325 | 0.78 | TRPA1 (0.63) | RAB9ATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1387841-B1 | NOVEL AZOLE OR TRIAZOLE DERIVATIVES, METHOD FOR PREPARING THE SAME AND USE THEREOF AS FUNGICIDES | AVENTIS PHARMA SA (FR) | 2006-03-08 | — | — | EP | disclosed |
| US-6960600-B2 | Azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments | AVENTIS PHARMA S.A. (FR) | 2005-11-01 | — | — | US | disclosed |
| US-6946460-B2 | Azole or triazole derivatives, method for preparing same and use thereof as fungicides | AVENTIS PHARMA S.A. (FR) | 2005-09-20 | — | — | US | disclosed |
| EP-1387837-B1 | NOVEL AZOLE OR TRIAZOLE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS ANTIFUNGAL MEDICINES | AVENTIS PHARMA SA (FR) | 2005-07-27 | — | — | EP | disclosed |
| US-20050043540-A1 | Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides | AVENTIS PHARMA S. A, (FR) | 2005-02-24 | — | — | US | disclosed |
| US-20040192922-A1 | Novel azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments | AVENTIS PHARMA S.A. (FR) | 2004-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043540-A1 | Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides | CYP1A2, CYP1B1, CYP21A2 | KCNH2 1556/4885RAB9A 2138/4885ACHE 2352/4885 |
| US-20040192922-A1 | Novel azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments | ERG28, CYP51A1, CYP3A7 | KCNH2 3337/4885RAB9A 2678/4885ACHE 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.